Purchase Order HHSN272201700983P
Award Date
8/15/17
Potential Completion Date
8/14/18
Potential Value
$41K
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services, to Maple Leaf Medical HIV Research Collaborative Inc., a non-profit organization. The $30,600.00 firm fixed-price purchase order is for screening and interviewing 18 HIV-infected patients, including collecting medical history, blood samples, and specimen shipping. The contract does not have a set-aside designation. This award...
<p>This $30,600.00 Firm Fixed Price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Maple Leaf Medical HIV Research Collaborative Inc., a non-profit organization, for HIV infected patient screening, interviewing, and follow-up services. The contract has an ultimate completion date of January 8, 2016 and was awarded on May 8, 2015. This contract is not associated with a set-aside program.</p>
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) awarded a $52,700.00 firm fixed price purchase order to Maple Leaf Medical HIV Research Collaborative Inc., a non-profit organization, to provide HIV patient screening, collection of specimens, and gathering of medical history for 24 pre-determined patients over the period from August 1, 2019 to December 31, 2019. This sole source award was made under the...
<p>This is a $40,800.00 firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Maple Leaf Medical HIV Research Collaborative Inc., a non-profit organization, for human cell enrichment kits. The contract has a completion date of December 31, 2018 and does not utilize any set-aside designations. The place of performance is located in Ottawa, Ontario, Canada.</p>
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS). The $128,312.76 cost-plus-fixed-fee contract was awarded to Southern Research Institute, a non-profit organization that provides research and development services, to develop new assays for HIV therapeutics and topical microbicides. The contract does not have a set-aside designation. Southern Research Institute...
This is a $403,478.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Southern Research Institute, a non-profit research organization. The contract is for conducting hit-to-lead progression studies on investigational agents for the treatment of HIV. This work will be performed under NIAID's Preclinical Services for HIV Therapeutics indefinite...
This federal contract award, valued at $499,879.67, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit research organization. The contract is for the identification of lead compounds to inhibit HIV, as part of NIAID's broader "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program. The contract is a Delivery Order...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit research organization. The $999,976 cost-plus-fixed-fee contract is for services to identify inhibitors of HIV-1 capsid dimerization as part of NIAID's In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides program. The contract has no set-aside designation and is...
This federal contract award, with an ID of 75N91019D00024|75N91019F00137, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The $9,235,930.00 cost-plus-fixed-fee contract was awarded to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., to complete HIV studies intended to describe the characteristics, course, and treatment response of HIV disease in the study population. The...
The federal contract award, HHSN272201600008I|HHSN27200001, was granted by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract is for $4,669,061.95 and is for quality assurance/quality control (QA/QC) services in support of the NIAID's Comprehensive Resources for HIV Microbicides and Biomedical Prevention...